Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

HAE Speaks

HAE Speaks artwork

Nina's HAE Treatment Journey

Oct 21, 202637 minAudio
ShareXLinkedInFacebookWhatsAppEmail

This month’s episode of HAE Speaks provides insight into living with hereditary angioedema (HAE) and treatment with TAKHZYRO® (lanadelumab-flyo), a prescription medicine used to prevent attacks of HAE in people two years of age and older. Join Chaeli Wallace, Takeda’s Senior Manager for Patient Community and Education, as she interviews Nina, a person living with HAE, about her journey from diagnosis to treatment with TAKHZYRO. Thank you to Takeda for sponsoring this episode! What is TAKHZYRO? TAKHZYRO (lanadelumab-flyo) is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 2 years of age and older. It is not known if TAKHZYRO is safe and effective in children under 2 years of age. IMPORTANT SAFETY INFORMATION TAKHZYRO may cause serious side effects, including allergic reactions. Call your healthcare provider or get emergency help right away if you have any of the following symptoms: wheezing difficulty breathing chest tightness fast heartbeat faintness rash hives The most common side effects seen with TAKHZYRO were injection site reactions (pain, redness, and bruising), upper respiratory infection, headache, rash, dizziness, diarrhea, and muscle aches. These are not all the possible side effects of TAKHZYRO. For more information, ask your healthcare provider or pharmacist. You may report side effects to FDA at 1-800-FDA-1088. TAKHZYRO has not been studied in pregnant or breastfeeding women. Talk to your healthcare provider about the risk of taking TAKHZYRO if you are pregnant, plan to be pregnant, are breastfeeding, or plan to breastfeed. Please see full Important Safety Information within the podcast and full Prescribing Information for TAKHZYRO here.

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. Less Stress, More Joy! Holiday Wellness Tips from the HAEA Health Team!

    Nov 3, 20265 minAudio

    The holidays can be a wonderful time for joy and connection, but they can also bring added stress. Join the HAEA Health Team for practical tips to manage holiday stress, prioritize your well-being, and enjoy meaningful...

    Credit the people on this episode

  2. Choosing Coverage with Confidence: An HAE Patient's Guide to Open Enrollment with CSL

    Oct 6, 202624 minAudio

    Learn what to consider when choosing a health insurance plan during Open Enrollment. The conversation covers medication coverage, prior authorizations, specialty pharmacies, out-of-pocket costs, provider networks, and...

    Credit the people on this episode

  3. End of Year Legislative Update: What it Means for the HAEA Community

    Oct 6, 202618 minAudio

    In this episode, HAEA Advocacy Director, Jess Myers, sits down with Dane Christiansen, the Managing Partner of the Health and Medicine Counsel of Washington, for a special end-of-year legislative update. Together, they...

    Credit the people on this episode

  4. Transitioning to Medicare: Helpful Insights from the HAEA Health Team

    Oct 6, 20268 minAudio

    In this episode, two compassionate advocates for the health and wellbeing of our community, Troyce Venturella, HAEA Director of Health & Research Services, and Mandy Granat, HAEA Health Services Manager, discuss what...

    Credit the people on this episode

  5. HAE Speaks: Roundtable with the CEO - Tony Has a Conversation with a CSL Executive Director

    Aug 20, 202614 minAudio

    In this new HAE Speaks Podcast series, Tony (HAEA CEO & Chairman of the Board) sits down with Tom Groeling, Executive Director of Specialty Franchise at CSL. Together, they discuss CSL's long-standing commitment to the...

    Credit the people on this episode